131I treatment for thyroid cancer in patients under haemodialysis (HD)

被引：0
|
作者：
Magri, G. C. [1 ]
De Agostini, A.
Movili, E. [2 ,3 ]
Gabanelli, S. V. [4 ]
Merli, G. [4 ]
Rodella, C. A.
Caobelli, F. [4 ]
Jeannin, G. [2 ,3 ]
Zubani, R. [2 ,3 ]
Giubbini, R. [4 ]
机构：
[1] Spedali Civil Brescia, Dpt Nucl Med, I-25125 Brescia, Italy
[2] Univ Brescia, Div Nephrol, I-25121 Brescia, Italy
[3] Univ Brescia, Chair Nephrol, I-25121 Brescia, Italy
[4] Univ Brescia, Chair Nucl Med, I-25121 Brescia, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [21] Radioactive discharge from patients with thyroid cancer under 131I treatment and its safe disposal to the public sewer system
    Tavakoli, Mohamad Bagher
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (01): : 38 - 41
  • [22] Thyroid cancer after exposure to radioactive 131I
    Holm, Lars-Erik
    ACTA ONCOLOGICA, 2006, 45 (08) : 1037 - 1040
  • [23] THYROID ANTIBODIES AFTER 131I TREATMENT FOR HYPERTHYROIDISM
    EINHORN, J
    FAGRAEUS, A
    JONSSON, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (09): : 1218 - +
  • [24] THYROID CANCER AFTER 131I THERAPY FOR THYROTOXICOSIS
    STAFFURTH, JS
    BRITISH JOURNAL OF RADIOLOGY, 1966, 39 (462): : 471 - +
  • [25] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [26] Thyroid Cancer Therapy with 131I: A Comprehensive Review
    Rodriguez-Santiago, Stephanie
    Cantu, Ernesto
    Wagner, Robert
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [27] Serum thyroglobulin in evaluating the response to 131I treatment in patients with distant metastatic differentiated thyroid cancer
    慕转转
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 130 - 131
  • [28] Radiation Protection Recommendations for Releasing Patients Treated with 131I for Thyroid Cancer
    Mora Ramirez, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S353 - S353
  • [29] 131I effective half-life (Teff) for patients with thyroid cancer
    Willegaignon, J.
    Malvestiti, Luiz F.
    Guimaraes, Maria I. C.
    Sapienza, Marcelo T.
    Endo, Irene S.
    Neto, Guilherme C.
    Marone, Marilia
    Sordi, Gian-Maria A. A.
    HEALTH PHYSICS, 2006, 91 (02): : 119 - 122
  • [30] Risk of Infertility in Reproductive-Age Patients With Thyroid Cancer Receiving or Not Receiving 131I Treatment
    Lin, Chun-Yi
    Lin, Cheng-Li
    Kao, Chia-Hung
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (03) : 201 - 207
12345